Considering bias and conflicts of interest among the included studies

I Boutron, MJ Page, JPT Higgins… - … systematic reviews of …, 2019 - Wiley Online Library
Bias can arise because of the actions of primary study investigators or because of the
actions of review authors, or may be unavoidable due to constraints on how research can be …

Industry sponsorship and research outcome

A Lundh, J Lexchin, B Mintzes… - … of systematic reviews, 2017 - cochranelibrary.com
Background Clinical research affecting how doctors practice medicine is increasingly
sponsored by companies that make drugs and medical devices. Previous systematic …

SPIRIT 2013 explanation and elaboration: guidance for protocols of clinical trials

AW Chan, JM Tetzlaff, PC Gøtzsche, DG Altman… - Bmj, 2013 - bmj.com
High quality protocols facilitate proper conduct, reporting, and external review of clinical
trials. However, the completeness of trial protocols is often inadequate. To help improve the …

Statins for the primary prevention of cardiovascular disease

F Taylor, K Ward, THM Moore, M Burke… - Cochrane database …, 2011 - cochranelibrary.com
Background Reducing high blood cholesterol, a risk factor for cardiovascular disease (CVD)
events in people with and without a past history of coronary heart disease (CHD) is an …

CONSORT 2010 explanation and elaboration: updated guidelines for reporting parallel group randomised trials

D Moher, S Hopewell, KF Schulz, V Montori… - Bmj, 2010 - bmj.com
Overwhelming evidence shows the quality of reporting of randomised controlled trials
(RCTs) is not optimal. Without transparent reporting, readers cannot judge the reliability and …

Effects of glucagon-like peptide-1 receptor agonists on weight loss: systematic review and meta-analyses of randomised controlled trials

T Vilsbøll, M Christensen, AE Junker, FK Knop… - Bmj, 2012 - bmj.com
Objective To determine whether treatment with agonists of glucagon-like peptide-1 receptor
(GLP-1R) result in weight loss in overweight or obese patients with or without type 2 …

The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration

A Liberati, DG Altman, J Tetzlaff, C Mulrow… - Annals of internal …, 2009 - acpjournals.org
Systematic reviews and meta-analyses are essential to summarize evidence relating to
efficacy and safety of health care interventions accurately and reliably. The clarity and …

Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): explanation and elaboration

JP Vandenbroucke, E Elm, DG Altman… - Annals of internal …, 2007 - acpjournals.org
Much medical research is observational. The reporting of observational studies is often of
insufficient quality. Poor reporting hampers the assessment of the strengths and …

[HTML][HTML] Effects of home telemonitoring interventions on patients with chronic heart failure: an overview of systematic reviews

S Kitsiou, G Paré, M Jaana - Journal of medical Internet research, 2015 - jmir.org
Background Growing interest on the effects of home telemonitoring on patients with chronic
heart failure (HF) has led to a rise in the number of systematic reviews addressing the same …

Reporting and interpretation of randomized controlled trials with statistically nonsignificant results for primary outcomes

I Boutron, S Dutton, P Ravaud, DG Altman - Jama, 2010 - jamanetwork.com
Context Previous studies indicate that the interpretation of trial results can be distorted by
authors of published reports. Objective To identify the nature and frequency of distorted …